Monovalent glycoconjugates of sulforaphane prevent inflammation induced by lipopolysaccharide in human dendritic cells by inhibiting NF‐ĸB signalling pathway
The integration of food therapeutic strategies not only enhances the stability and delivery of bioactive compounds but also broadens their potential applications in functional foods and therapeutic approaches. In particular, SFN-glycoconjugates represent a promising option as biologically active compounds for inflammatory diseases, offering enhanced anti-inflammatory and immunomodulatory effects through optimized delivery systems and the activation of specific molecular pathways.
Authors
- Soledad López (ORCID: https://orcid.org/0000-0003-3727-1843)
- Francisca Palomares (ORCID: https://orcid.org/0000-0001-5591-7877)
- Macarena Martínez‐Bailén (ORCID: https://orcid.org/0000-0001-6924-5151)
- Ana Maria Múnera‐Rodríguez
- Camila Leiva‐Castro
- Ana T. Carmona (ORCID: https://orcid.org/0000-0003-1058-7127)
Institutions
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1111/bph.70115
- Citations
- 4
- Primary Topic
- Genomics, phytochemicals, and oxidative stress
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- Universidad de Sevilla
- European Commission
- Ministerio de Ciencia e Innovación
- Asociación Universitaria Iberoamericana de Postgrado
- European Regional Development Fund
- Agencia Estatal de Investigación
- European Social Fund